Proportions of women receiving standard of care services as shown by quality indicators, 1999–2011.
| Quality indicator | Non–First Nations mothers n/N (%) | First Nations mothers n/N (%) | Risk difference (95% CI) | Adjusted*† risk difference (95% CI) |
|---|---|---|---|---|
| GBS screening at or after term | 107 588/191 123 (56.3) | 4 357/8 165 (53.4) | −2.9 (−4.0 to −1.8) | −1.7 (−2.9 to −0.6) |
| Use of antibiotics by mothers with a positive GBS test result | 22 535/25 156 (89.6) | 934/1 049 (89.0) | −0.5 (−2.5 to 1.4) | −0.6 (−2.5 to 1.4) |
| At least 4 antenatal visits in women with births in the 39th week | 47 470/48 419 (98.0) | 1 990 /2 120 (93.9) | −4.2 (−5.2 to −3.1) | −3.6 (−4.6 to −2.6) |
| Performance of an early ultrasound | 148 817/206 841 (71.9) | 5 361/9 152 (58.6) | −13.4 (−14.4 to 12.3) | −10.2 (−11.3 to −9.3) |
| Medical induction in prelabour rupture of membranes at term | ||||
| > 1 h | 17 182/46 592 (36.9) | 506/1 564 (32.4) | −4.5 (−6.9 to −2.2) | −3.7 (−6.1 to −1.3) |
| > 12 h | 9 137/ 18 206 (50.2) | 277/635 (43.6) | −6.6 (−10.5 to −2.6) | −4.9 (−8.9 to −0.9) |
| > 24 h | 4 917/7 336 (67.0) | 162/278 (58.3) | −8.8 (−14.6 to −2.9) | −5.9 (−11.8 to 0.1) |
| Medical induction in women reaching post-dates | ||||
| Overall | 17 681/35 779 (49.4) | 373/971 (38.4) | −11.0 (−14.1 to −7.9) | −10.6 (−13.8 to −7.5) |
| In women with early ultrasonography | 11 761/22 877 (51.4) | 191/423 (45.2) | −6.3 (−11.0 to −1.5) | −6.3 (−11.1 to −1.4) |
| In women without early ultrasonography | 5 920/12 902 (45.9) | 182/548 (33.2) | −12.7 (−16.7 to −8.6) | −12.1 (−16.3 to −8.0) |
| Timing of planned cesarean delivery for breech presentation | 1 929/4 631 (41.7) | 40/90 (44.4) | 2.8 (−7.6 to 13.2) | 1.04 (0.68 to 1.60) |